• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从携带LRRK2 p.I2012T突变的帕金森病患者中诱导产生多能干细胞。

Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.

作者信息

Lin Chin-Hsien, Cheng Yu-Che, Lin Han-I, Ho Ming-Ching, Hsu Yu-Hung, Wen Cheng-Hao, Ko Hui-Wen, Lu Huai-En, Huang Ching-Ying, Hsieh Patrick C H

机构信息

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.

Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan.

出版信息

Stem Cell Res. 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020. Epub 2017 Oct 31.

DOI:10.1016/j.scr.2017.10.020
PMID:29127874
Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by interactions between genetic and environmental factors. Leucine rich repeat kinase (LRRK2) is the most prevalent mutation in autosomal-dominant inheritance of PD. Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with p.I2012T mutation in LRRK2 gene by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the 3 germ layers in vivo. This cellular model will provide a useful platform for further pathophysiological studies of PD.

摘要

帕金森病(PD)是一种由遗传和环境因素相互作用引起的进行性神经退行性疾病。富含亮氨酸重复激酶(LRRK2)是帕金森病常染色体显性遗传中最常见的突变。在此,我们通过仙台病毒递送系统,从一名LRRK2基因发生p.I2012T突变的女性患者的外周血单个核细胞中生成了诱导多能干细胞(iPSC)。所产生的iPSC具有正常的核型。这些iPSC通过免疫荧光染色证实具有多能性,并在体内分化为三个胚层。该细胞模型将为帕金森病进一步的病理生理学研究提供一个有用的平台。

相似文献

1
Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.从携带LRRK2 p.I2012T突变的帕金森病患者中诱导产生多能干细胞。
Stem Cell Res. 2017 Dec;25:123-127. doi: 10.1016/j.scr.2017.10.020. Epub 2017 Oct 31.
2
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.源自携带LRRK2 G2385R变异的帕金森病患者的2个诱导多能干细胞系的产生。
Stem Cell Res. 2018 Apr;28:1-5. doi: 10.1016/j.scr.2018.01.034. Epub 2018 Feb 28.
3
Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.从携带LRRK2 p.I1371V突变的帕金森病患者中生成诱导多能干细胞(IBMSi011-A)。
Stem Cell Res. 2019 May;37:101447. doi: 10.1016/j.scr.2019.101447. Epub 2019 Apr 22.
4
Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.携带与帕金森病相关的LRRK2变异体S1647T的人诱导多能干细胞(iPSC)系的产生。
Stem Cell Res. 2017 Jan;18:54-56. doi: 10.1016/j.scr.2016.12.010. Epub 2016 Dec 9.
5
Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.从一名在亮氨酸丰富重复激酶 2(LRRK2)基因中携带 p.G2019S 突变的帕金森病患者身上生成诱导多能干细胞系(CSC-41)。
Stem Cell Res. 2018 Apr;28:44-47. doi: 10.1016/j.scr.2018.01.022. Epub 2018 Feb 2.
6
Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.从一名携带LRRK2基因R1628P变体的帕金森病患者身上重编程出的人类诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:45-47. doi: 10.1016/j.scr.2016.12.011. Epub 2016 Dec 10.
7
Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.从一名携带LRRK2基因N551K变体的帕金森病患者身上开发人诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Jan;18:51-53. doi: 10.1016/j.scr.2016.12.013. Epub 2016 Dec 8.
8
Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2.从携带 LRRK2 基因 I2020T 突变的家族性帕金森病 PARK8 患者诱导多能干细胞中生成基因校正的诱导多能干细胞系(KEIUi001-A)。
Stem Cell Res. 2020 Dec;49:102073. doi: 10.1016/j.scr.2020.102073. Epub 2020 Nov 3.
9
Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.从一名携带LRRK2 I1371V变异的东印度裔帕金森病患者中生成诱导多能干细胞(NIMHi001-A)。
Stem Cell Res. 2020 Apr;44:101768. doi: 10.1016/j.scr.2020.101768. Epub 2020 Mar 17.
10
Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.从携带双基因突变 LRRK2 p.G2019S 和 GBA1 p.N409S 的帕金森病患者中诱导多能干细胞的产生和特性鉴定。
Stem Cell Res. 2023 Oct;72:103212. doi: 10.1016/j.scr.2023.103212. Epub 2023 Sep 28.

引用本文的文献

1
In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.体外基因编辑挽救了携带 LRRK2 p.G2019S 突变的诱导多能干细胞衍生的多巴胺能神经元帕金森病表型。
Stem Cell Res Ther. 2021 Sep 22;12(1):508. doi: 10.1186/s13287-021-02585-2.
2
Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.使用诱导多能干细胞神经元模型来研究神经退行性疾病。
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165431. doi: 10.1016/j.bbadis.2019.03.004. Epub 2019 Mar 18.